文章基本信息

标题：PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets
本地全文：下载
作者：Xu Hou ; Anil Kumar ; Chunsik Lee 等
期刊名称：Proceedings of the National Academy of Sciences
印刷版ISSN：0027-8424
电子版ISSN：1091-6490
出版年度：2010
卷号：107
期号：27
页码：12216-12221
DOI：10.1073/pnas.1004143107
语种：English
出版社：The National Academy of Sciences of the United States of America
摘要：The importance of identifying VEGF-independent pathways in pathological angiogenesis is increasingly recognized as a result of the emerging drug resistance to anti-VEGF therapies. PDGF-CC is the third member of the PDGF family discovered after more than two decades of studies on PDGF-AA and PDGF-BB. The biological function of PDGF-CC and the underlying cellular and molecular mechanisms remain largely unexplored. Here, using different animal models, we report that PDGF-CC inhibition by neutralizing antibody, shRNA, or genetic deletion suppressed both choroidal and retinal neovascularization. Importantly, we revealed that PDGF-CC targeting acted not only on multiple cell types important for pathological angiogenesis, such as vascular mural and endothelial cells, macrophages, choroidal fibroblasts and retinal pigment epithelial cells, but also on the expression of other important angiogenic genes, such as PDGF-BB and PDGF receptors. At a molecular level, we found that PDGF-CC regulated glycogen synthase kinase (GSK)-3{beta} phosphorylation and expression both in vitro and in vivo. Activation of GSK3{beta} impaired PDGF-CC-induced angiogenesis, and inhibition of GSK3{beta} abolished the antiangiogenic effect of PDGF-CC blockade. Thus, we identified PDGF-CC as an important candidate target gene for antiangiogenic therapy, and PDGF-CC inhibition may be of therapeutic value in treating neovascular diseases.
关键词：choroidal neovascularization ; glycogen synthase kinase-3β ; vascular biology ; retinal neovascularization ; ocular disease